Autoimmune hemolytic anemias (AIHAs) are rare and heterogeneous disorders
characterized by the destruction of red blood cells through warm or cold antibodies. There is …

Autoimmune hemolytic anemia (AIHA) is a relatively uncommon disorder caused by
autoantibodies directed against self red blood cells. It can be idiopathic or secondary, and …

The article presents guidelines for the diagnosis and management of patients with primary
autoimmune haemolytic anaemia (AIHA). Topics discussed include diagnostic approach to …

The clinical outcome, response to treatment, and occurrence of acute complications were
retrospectively investigated in 308 primary autoimmune hemolytic anemia (AIHA) cases and …

The terminology applied to autoimmune hemolytic anemia (AIHA) seems inconsistent. We
aimed to evaluate the consistency of definitions used for diagnosis and treatment. In this …

New insights into childhood autoimmune hemolytic anemia: a French national observational
study of 265 children - PMC Back to Top Skip to main content NIH NLM Logo Access keys …

Summary The management of Evans Syndrome in children is challenging due to the lack of
evidence‐based data on treatment. Steroids, the first‐choice therapy, are successful in …

The treatment of both auto‐immune haemolytic anaemia (AIHA) and auto‐immune
thromobocytopenic purpura (AITP) remains unsatisfactory in those refractory to first‐line …

Autoimmune hemolytic anemia (AIHA) is a rare disease in children, presenting with variable
severity. Most commonly, warm-reactive IgG antibodies bind erythrocytes at 37° C and …

Introduction: Autoimmune hemolytic anemia (AIHA) is a heterogeneous disease mainly due
to autoantibody-mediated destruction of erythrocytes but also involves complement …